Glycine inhibits the LPS-induced increase in cytosolic Ca2+ concentration and TNFalpha production in cardiomyocytes by activating a glycine receptor

Acta Pharmacol Sin. 2009 Aug;30(8):1107-14. doi: 10.1038/aps.2009.106. Epub 2009 Jul 20.

Abstract

Aim: Previous studies have demonstrated that glycine (GLY) markedly reduces lipopolysaccharide (LPS)-induced myocardial injury.However, the mechanism of this effect is still unclear. The present study investigated the effect of GLY on cytosolic calcium concentration([Ca2+]c) and tumor necrosis factor-alpha (TNFalpha) production in cardiomyocytes exposed to LPS, as well as whether the glycine-gated chloride channel is involved in this process.

Methods: Neonatal rat cardiomyocytes were isolated, and the [Ca2+]c and TNFalpha levels were determined by using Fura-2 and a Quantikine enzyme-linked immunosorbent assay, respectively. The distribution of the GLY receptor and GLY-induced currents in cardiomyocytes were also investigated using immunocytochemistry and the whole-cell patch-clamp technique, respectively.

Results: LPS at concentrations ranging from 10 ng/mL to 100 microg/mL significantly stimulated TNFalpha production. GLY did not inhibit TNFalpha production induced by LPS at concentrations below 10 ng/mL but did significantly decrease TNFalpha release stimulated by 100 microg/mL LPS and prevented an LPS-induced increase in [Ca2+]c, which was reversed by strychnine, a glycine receptor antagonist. GLY did not block the isoproterenol-induced increase in [Ca2+]c, but did prevent the potassium chloride-induced increase in [Ca2+]c in cardiomyocytes.Strychnine reversed the inhibition of the KCl-stimulated elevation in [Ca2+]c by GLY. In chloride-free buffer, GLY had no effect on the dipotassium hydrogen phosphate-induced increase in [Ca2+]c. Furthermore, GLY receptor alpha1 and beta subunit-immunoreactive spots were observed in cardiomyocytes, and GLY-evoked currents were blocked by strychnine.

Conclusion: Cardiomyocytes possess the glycine-gated chloride channel, through which GLY prevents the increase in [Ca2+]c and inhibits the TNFalpha production induced by LPS at high doses in neonatal rat cardiomyocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Cardiotonic Agents / pharmacology
  • Cells, Cultured
  • Glycine / pharmacology*
  • Glycine Agents / pharmacology
  • Isoproterenol / pharmacology
  • Lipopolysaccharides / adverse effects
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / metabolism
  • Phosphates / metabolism
  • Potassium Chloride / metabolism
  • Potassium Compounds / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Glycine / agonists*
  • Receptors, Glycine / metabolism*
  • Strychnine / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Cardiotonic Agents
  • Glycine Agents
  • Lipopolysaccharides
  • Phosphates
  • Potassium Compounds
  • Receptors, Glycine
  • Tumor Necrosis Factor-alpha
  • Potassium Chloride
  • potassium phosphate
  • Strychnine
  • Isoproterenol
  • Calcium
  • Glycine